Plus Therapeutics, Inc. Stock Forecast
Red day on Wednesday for Plus Therapeutics, Inc. stock after losing 1.18%
(Updated on May 01, 2024)
The Plus Therapeutics, Inc. stock price fell by -1.18% on the last day (Wednesday, 1st May 2024) from $1.74 to $1.72. During the last trading day the stock fluctuated 4.47% from a day low at $1.71 to a day high of $1.78. The price has fallen in 6 of the last 10 days and is down by -2.55% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 5 thousand shares were bought and sold for approximately $8.62 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.09% during the next 3 months and, with a 90% probability hold a price between $1.37 and $1.72 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PSTV Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 7.50%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Plus Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.78. On a fall, the stock will find some support from the short-term average at $1.67. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Plus Therapeutics, Inc. stock
Plus Therapeutics, Inc. finds support from accumulated volume at $1.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0763 between high and low, or 4.47%. For the last week the stock has had daily average volatility of 4.71%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (PSTV) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect Plus Therapeutics, Inc. to open at $1.74, and during the day (based on 14 day Average True Range), to move between $1.61 and $1.83, which gives a possible trading interval of +/-$0.112 (+/-6.50%) up or down from last closing price. If Plus Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.00% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.73 (0.58%) than the support at $1.66 (3.49%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Plus Therapeutics, Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.250. We will update the financials statements for Plus Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.07% in the first trading day after earnings release.
Is Plus Therapeutics, Inc. stock A Buy?
Plus Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.021 Sell Candidate Unchanged
Predicted Opening Price for Plus Therapeutics, Inc. of Thursday, May 2, 2024
Fair opening price May 2, 2024 | Current price |
---|---|
$1.74 ( 0.97%) | $1.72 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PSTV
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.81 | 5.41 % | |
R2 | 1.78 | 3.71 % | ||
R1 | 1.77 | 2.67 % | ||
Current price: | 1.72 | |||
Support | S1 | 1.71 | -0.724 % | |
S2 | 1.69 | -1.77 % | ||
S3 | 1.66 | -3.47 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.94 | 12.79 % | |
R2 | 1.89 | 9.88 % | ||
R1 | 1.73 | 0.581 % | ||
Current price | 1.72 | |||
Support | S1 | 1.66 | -3.49% | |
S2 | 1.63 | -5.23% | ||
S3 | 1.61 | -6.40% |
FAQ
Click here for our free guide on how to buy Plus Therapeutics, Inc. Stock.